Amanda Vest
Advanced Heart Failure and Transplant Cardiology · Cleveland, OHNPI 1831365626
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Medtronic at 57.3% of the total. Reporting peaked in 2019 at $2,100 and has fallen 64.0% since, to $755 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in OH, where the typical reported total is $4,421.
Across 17 payments — averaging $215.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$729
- Endotronix, Inc.$272
- Impulse Dynamics (USA) Inc.$158
- Scpharmaceuticals Inc.$142
- Bayer$118
- plus $145 from 2 others
Across 89 payments — averaging $808.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$55K
- Boehringer Ingelheim Pharma GmbH & Co.kg$17K
What the payments were for
- Speaking & faculty fees$2,10057%
- Food & beverage$1,56443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $2,100 |
| Abbott | 9 | $729 |
| Endotronix, Inc. | 1 | $272 |
| Impulse Dynamics (USA) Inc. | 2 | $158 |
| Scpharmaceuticals Inc. | 1 | $142 |
| Bayer | 1 | $118 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $114 |
| Boehringer Ingelheim | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,664 in reported general payments places this provider in the 45th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.
See all advanced heart failure and transplant cardiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 38 | $896,419 |
| JardianceEmpagliflozin | 143 | $172,796 |
| EntrestoSacubitril/Valsartan | 102 | $135,929 |
| FarxigaDapagliflozin Propanediol | 42 | $42,632 |
| EliquisApixaban | 25 | $34,896 |
| OzempicSemaglutide | 37 | $33,799 |
| MounjaroTirzepatide | 19 | $20,423 |
| Atovaquone | 26 | $14,267 |
| Sirolimus | 13 | $11,507 |
| Repatha SureclickEvolocumab | 18 | $9,589 |
| Mycophenolate Mofetil | 22 | $7,766 |
| Metoprolol Succinate | 110 | $1,965 |
| Nystatin | 30 | $1,801 |
| Tacrolimus | 28 | $1,761 |
| Ranolazine ErRanolazine | 11 | $1,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $30 | $172,796143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.
Other advanced heart failure and transplant cardiology in Cleveland
- Andres Carmona RubioCleveland$27K
- Pavan BhatCleveland$16K
- Robert MontgomeryCleveland$9K
- Sanjeeb BhattacharyaCleveland$7K
- Tuoyo Mene-AfejukuCleveland$6K
- Ran LeeCleveland$5K
- Chonyang AlbertCleveland$4K
- Leon ZhouCleveland$3K
- Karlee HoffmanCleveland$2K
- Michael HillCleveland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.